encyclopedia of medical concepts
ψ 
ψ 

Phospholipases

More information in Books or onNLM PubMed
Definition: A class of enzymes that catalyze the hydrolysis of phosphoglycerides or glycerophosphatidates. EC 3.1.-.     
Examples Lysophospholipase; Phospholipases A 		Other names Lecithinases; Phospholipase; Lecithinase
 
SubstanceCAS Registry & nameCategoriesSourceDrugs*
DDHD2 protein, human  EC 3.1.1.-   *Phospholipases. Oncogene 2009 Apr 30;28(17):1892-903
Abh4 protein, mouse  EC 1.14.11.-   *Phospholipases. J Biol Chem 2006 Sep 8;281(36):26465-72
Hev b 4 allergen, Hevea brasiliensis  EC 3.1.-   *Phospholipases *Antigens, Plant Glycoproteins. Clin Exp Allergy 2005 Nov;35(11):1490-5
phospholipase IVC, Arabidopsis  EC 3.1.-   *Phospholipases *Arabidopsis Proteins. Plant Physiol 2002 Sep;130(1):90-101
phospholipase IVA, Arabidopsis  EC 3.1.-   *Phospholipases *Arabidopsis Proteins. Plant Physiol 2002 Sep;130(1):90-101
phospholipase IIA, Arabidopsis  EC 3.1.-   *Phospholipases *Arabidopsis Proteins. Plant Physiol 2002 Sep;130(1):90-101
SGR2 protein, Arabidopsis  EC 3.1.-   *Phospholipases *Arabidopsis Proteins. Plant Cell 2002 Jan;14(1):33-46
2-chloro-3-((4-ethyl-phenyl)-amino)-1,4-naphthalendione  0   *Naphthalenes Phospholipases/antagonists & inhibitors. Res Commun Mol Pathol Pharmacol 1999 ;104(2):165-72
1-thio-octyl-2-heptylphosphonyl-1-deoxyglycero-3-phosphoglycol  0   *Phospholipids Phospholipases/antagonists & inhibitors. Nat Struct Biol 1995 May;2(5):402-3
diepoxin sigma  152697-41-1 Spiro(2a,6a-epoxynaphth(2,3-b)oxirene-2(1aH),2'-naphtho(1,8-de)(1,3)dioxin)-3,7(6H,7aH)-dione, 6-hydroxy-,(1aS-(1aalpha,2abeta,6alpha,6abeta,7aalpha))  *Epoxy Compounds *Spiro Compounds Phospholipases/antagonists & inhibitors. Anticancer Drug Des 1994 Aug;9(4):363-72
SCH 49210  151702-60-2 Spiro02a,6a-epoxynaphth(02,3-b)oxirene-2(7H),(((2'-naphtho01,8-de)01,3)dioxin)-7-one, 1a,3,4,5,6,7a-hexahydro-3,6-dihydroxy-, (1aalpha,2abeta,3alpha,6alpha,6abeta,7aalpha)  *Epoxy Compounds *Spiro Compounds Phospholipases/antagonists & inhibitors. Anticancer Drug Des 1994 Aug;9(4):363-72
AGN 190383  120755-15-9   *Furans Phospholipases/antagonists & inhibitors. Agents Actions 1991 Sep;34(1-2):70-72
Notechis 11'2  120930-83-8   *Elapid Venoms Phospholipases. Eur J Biochem 1991;202(2):493
TMVPLA2 II  EC 3.1.-   *Phospholipases Crotalid Venoms. J Pharm Pharmacol 1990;42(12):846
TMVPLA2 I  EC 3.1.-   *Phospholipases. J Pharm Pharmacol 1990;42(12):846
scutoxin A  132444-97-4 Scutoxin A  *Elapid Venoms Phospholipases. Toxicon 1991;29(1):85
ammodytoxin A  97089-72-0   *Viper Venoms Phospholipases. FEBS Lett 1991;280(1):175
methionyl-leucyl-phenylalanyl-isoleucyl-lysyl-arginyl-seryl-arginyl-histidyl-phenylalanine  92237-18-8 L-Phenylalanine, N-(N-(N2-(N-(N2-(N2-(N-(N-(N-(N-(N-L-methionyl-L-leucyl)-L-phenylalanyl)-L-isoleucyl)-L-leucyl)-L-isoleucyl)-L-lysyl)-L-arginyl)-L-seryl)-L-arginyl)-L-histidyl)-, (SP-4-2)  *Peptide Fragments Phospholipases/antagonists & inhibitors. Arch Biochem Biophys 1985;236(1):195
notechis 5  0   *Elapid Venoms Phospholipases. Clin Exp Pharmacol Physiol 5(6):587;1978; J Biol Chem 251(23):7343;1976; J Neurochem 31(4):969;1978

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy